MSPrebiotic® – a St. Boniface Hospital Research success story out of Carberry, Manitoba – is leading a revolution in gut health.
A clinical trial conducted by Canadian Centre for Agri-Food Research in Health and Medicine (CCARM) Principal Investigator and Medical Microbiologist Dr. Michelle Alfa contributed to the development of the commercial product, MSPrebiotic®, used for improving gut health in adults. The natural health supplement is manufactured by MSPrebiotics Inc.
Prebiotics are non-digestible food ingredients that beneficially affect our digestive system by acting as food for probiotics. MSPrebiotic® helps improve digestive health by maintaining a good balance of bacteria in the digestive system. Better gut health means better health overall, helping to fight diseases and increase energy levels and immunities.
Better gut health means better health overall, helping to fight diseases and increase energy levels and immunities.
Dr. Alfa undertook a Health Canada-cleared prospective, randomized prebiotics clinical trial in partnership with Winnipeg Regional Health Authority’s Medical Director, Rehab & Geriatrics, Dr. David Strang. The trial evaluated the prebiotics in mid-age adults (30 to 50 years of age) as well as elderly adults (70 years and older).
The objective of the clinical trial was to determine if the consumption of MSPrebiotic® could alter microbiomes or decrease glucose and insulin resistance (thereby reducing the risk of Type 2 Diabetes).
The study found that MSPrebiotic® did help improve gut health in participants, and that there was also a significant reduction in blood glucose levels and insulin resistance in older adults. These findings indicate that MSPrebiotic® could be a valuable way to reduce the risk of Type 2 Diabetes.
An MSPrebiotic® Quickstart Trial Pack is available for less than $10.